Innovation Pharmaceuticals Inc (IPIX)

[Blues44]

"Challenges For Developing 502(b)(2) Drug Product, There are few additional challenges associated with the use of the 502(b)(2) pathway. These products face fierce competition from generics with similar biological properties and since they are more expensive than generics, a robust marketing campaign may be required to attract customer attention." This information may be found here; http://www.amarexcro.com/articles/docs/raps_focus_505b2_apr2010.pdf on page 12.